Evidence map›Paper›PMID 28077316›Full record

ArticleBiochimica et biophysica acta. Gene regulatory mechanisms2017

Chromatin dynamics regulate mesenchymal stem cell lineage specification and differentiation to osteogenesis.

Hai Wu, Jonathan A R Gordon, Troy W Whitfield, Phillip W L Tai, Andre J van Wijnen, Janet L Stein, Gary S Stein, Jane B Lian

Abstract read
In one paragraph

Article in Biochimica et biophysica acta. Gene regulatory mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Transcriptional networks controlling stromal cell differentiation.Nature reviews. Molecular cell biology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hai WuDepartment of Biochemistry and Vermont Cancer Center, University of Vermont, Burlington, VT, United States. Electronic address: Hai.wu@uvm.edu.
Jonathan A R GordonDepartment of Biochemistry and Vermont Cancer Center, University of Vermont, Burlington, VT, United States. Electronic address: Jonathan.A.Gordon@uvm.edu.
Troy W WhitfieldDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA, United States. Electronic address: Troy.Whitfield@umassmed.edu.
Phillip W L TaiDepartment of Biochemistry and Vermont Cancer Center, University of Vermont, Burlington, VT, United States. Electronic address: Phillip.Tai@umassmed.edu.
Andre J van WijnenDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States. Electronic address: vanwijnen.andre@mayo.edu.
Janet L SteinDepartment of Biochemistry and Vermont Cancer Center, University of Vermont, Burlington, VT, United States. Electronic address: Janet.Stein@uvm.edu.
Gary S SteinDepartment of Biochemistry and Vermont Cancer Center, University of Vermont, Burlington, VT, United States. Electronic address: Gary.Stein@uvm.edu.
Jane B LianDepartment of Biochemistry and Vermont Cancer Center, University of Vermont, Burlington, VT, United States. Electronic address: Jane.Lian@uvm.edu.

Funding

CONTROL OF OSTEOBLAST PROLIFERATION AND DIFFERENTIATIONR01AR039588 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B., STEIN, GARY S. · 1990 to 2019
$8.0M
Synthesis of Osteocalcin in BoneR37DE012528 · NIDCR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B. · 2008 to 2017
$5.0M
SYNTHESIS OF OSTEOCALCIN IN BONER01DE012528 · NIDCR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B · 1997 to 2006
$2.6M
NIAMS NIH HHS R01 AR039588NIDCR NIH HHS R01 DE012528NIDCR NIH HHS R37 DE012528
6 · The paper itself

Abstract

Multipotent mesenchymal stromal cells (MSCs) are critical for regeneration of multiple tissues. Epigenetic mechanisms are fundamental regulators of lineage specification and cell fate, and as such, we addressed the question of which epigenetic modifications characterize the transition of nascent MSCs to a tissue specific MSC-derived phenotype. By profiling the temporal changes of seven histone marks correlated to gene expression during proliferation, early commitment, matrix deposition, and mineralization stages, we identified distinct epigenetic mechanisms that regulate transcriptional programs necessary for tissue-specific phenotype development. Patterns of stage-specific enrichment of histone modifications revealed distinct modes of repression and activation of gene expression that would not be detected using single endpoint analysis. We discovered that at commitment, H3K27me3 is removed from genes that are upregulated and is not acquired on downregulated genes. Additionally, we found that the absence of H3K4me3 modification at promoters defined a subset of osteoblast-specific upregulated genes, indicating that acquisition of acetyl modifications drive activation of these genes. Significantly, loss or gain of H3K36me3 was the primary predictor of dynamic changes in temporal gene expression. Using unsupervised pattern discovery analysis the signature of osteogenic-related histone modifications identified novel functional cis regulatory modules associated with enhancer regions that control tissue-specific genes. Our work provides a cornerstone to understand the epigenetic regulation of transcriptional programs that are important for MSC lineage commitment and lineage, as well as insights to facilitate MSC-based therapeutic interventions.

Indexed as

AnimalsCell DifferentiationCell LineageChromatin Assembly and DisassemblyEpigenesis, GeneticGene Expression ProfilingHistonesMesenchymal Stem CellsMiceOsteoblastsOsteogenesisProtein Processing, Post-TranslationalTranscription, GeneticHistonesChIP-SeqChromatinEpigeneticsEpigenomicsGene expressionMesenchymal stromal cellsOsteoblast

Identifiers

PMID28077316
PMCPMC5385709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.